Clinical Trials · NCT01505673
Adding Liraglutide to High Dose Insulin: Breaking the Cycle
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Ildiko Lingvay
- Enrollment
- 71
- Start date
- Jan 2012
- Locations
- 1 site, United States
- Primary endpoint
- Glycemic Control Measured by HbA1c